MedPath

Turmeric in oral submucous fibrosis.

Phase 4
Completed
Conditions
Health Condition 1: null- Oral submucous fibrosis
Registration Number
CTRI/2017/08/009461
Lead Sponsor
Jamia Millia Islamia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
147
Inclusion Criteria

Patients satisfying all the inclusion criteria were enrolled which included current or previous use of any form of smokeless tobacco and/or areca nut (any duration and frequency); complains of burning sensation of mouth on having hot and spicy food and/or difficulty in swallowing and chewing; and presenting with clinical features like restricted mouth opening and/or changes in the oral mucous membrane including presence of vertical fibrous bands, stiffness, blanching and circum oral bands.

Exclusion Criteria

Patients with significant medical condition as defined by the investigator that interfered with the safety, treatment or compliance with the protocol; patients with known allergy or contra-indication to any of the ingredients of the antioxidants or turmeric; pregnant and lactating females; patients already undergoing treatment for OSMF and patients having concomitant pericoronitis or any other dental condition leading to trismus were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes studied were inter-incisal mouth opening; tongue protrusion and burning sensation on having food was recorded using Visual Analogue Scale (VAS) from 1 to 10 (with 10 being the most severe).Timepoint: every 15 days for 3 months
Secondary Outcome Measures
NameTimeMethod
The secondary outcomes studied were adverse reactions reported with the drugs used; habit cessation success rate and change in the color of mucosa (recorded as white, pale or pink).Timepoint: every 15 days for 3 months
© Copyright 2025. All Rights Reserved by MedPath